Crizotinib Impurity 40 | CAS 1269429-29-9 - Request Quote
Crizotinib Impurity 40
| SZ CAT No: | SZ-C148047 |
| CAS No | 1269429-29-9 |
| Mol.F. | C13H21N3O2 |
| Mol.Wt. | 251.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Crizotinib Impurity 40 is chemically Tert-butyl 4-(1H-pyrazol-1-yl)piperidine-1-carboxylate. Crizotinib Impurity 40 is supplied with detailed characterization data compliant with regulatory guideline. Crizotinib Impurity 40 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Crizotinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1269429-29-9
Purchase 1269429-29-9
Order 1269429-29-9
Enquire 1269429-29-9
price of 1269429-29-9
1269429-29-9 Supplier
1269429-29-9 Manufacturer
1269429-29-9 Exporter
buy high quality Crizotinib Impurity 40
Purchase Crizotinib Impurity 40
Crizotinib Impurity 40 suppliers
Crizotinib Impurity 40 manufacturers
Crizotinib Impurity 40 price
Order Crizotinib Impurity 40
Enquire Crizotinib Impurity 40
Crizotinib Impurity 40 cost
Crizotinib Impurity 40 Supplier
Crizotinib Impurity 40 Distributor
Crizotinib Impurity 40 for Method Validation
Crizotinib Reference Standard
Crizotinib Impurity 40 for ANDA Filing
Crizotinib Impurity 40 for Forced Degradation Studies
Crizotinib Impurity 40 Identification Standards
Crizotinib Impurity 40 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


